Published in Br J Urol on September 01, 1998
A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy (PROTOX) | NCT01275521
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol (1999) 4.85
Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A (2005) 2.77
Chemokines and BPH/LUTS. Differentiation (2011) 0.93
Chronic caffeine intake increases androgenic stimuli, epithelial cell proliferation and hyperplasia in rat ventral prostate. Int J Exp Pathol (2012) 0.81
Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple doses. Br J Clin Pharmacol (2002) 0.80
An introduction to acinar pressures in BPH and prostate cancer. Nat Rev Urol (2013) 0.79
Differential response to zinc-induced apoptosis in benign prostate hyperplasia and prostate cancer cells. J Nutr Biochem (2009) 0.77
Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia. Oncotarget (2016) 0.77
Caspase-3 expression in normal oral epithelium, oral submucous fibrosis and oral squamous cell carcinoma. J Oral Maxillofac Pathol (2016) 0.75
Pharmacological effects of saw palmetto extract in the lower urinary tract. Acta Pharmacol Sin (2009) 0.75
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem (2000) 6.86
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet (1999) 5.29
Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus. J Virol (1976) 3.94
Correlation between sagittal plane changes and adjacent segment degeneration following lumbar spine fusion. Eur Spine J (2001) 3.16
Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol (1993) 2.69
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol (2001) 2.55
Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology (1994) 2.41
Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol (2002) 2.34
Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev (1999) 2.12
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res (1995) 1.98
Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer (1995) 1.93
Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol (1992) 1.80
Laparoscopic radical prostatectomy with a remote controlled robot. J Urol (2001) 1.73
Synthetic porous ceramic compared with autograft in scoliosis surgery. A prospective, randomized study of 341 patients. J Bone Joint Surg Br (1998) 1.73
Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: a direct comparison. Neurourol Urodyn (2000) 1.58
Perineal approach to radical prostatectomy in kidney transplant recipients with localized prostate cancer. Urology (1999) 1.50
Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology (2000) 1.45
Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol (1999) 1.43
The mouse prostate reconstitution model of prostate diseases. Prostate (1997) 1.40
Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res (1992) 1.37
Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res (1995) 1.33
Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate (2001) 1.30
Apoptosis: molecular control point in toxicity. Toxicol Appl Pharmacol (1994) 1.28
Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. Oncogene (2006) 1.28
Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene (1999) 1.27
Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. Diabetes Metab (2003) 1.26
Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene (1997) 1.25
Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer (1995) 1.22
Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy. J Clin Microbiol (2001) 1.22
Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res (1997) 1.21
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem Pharmacol (1999) 1.18
Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression. J Pathol (2008) 1.17
Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas. Oncogene (1997) 1.16
Apoptosis in the rat penis after penile denervation. J Urol (1997) 1.15
Early removal of the catheter after laparoscopic radical prostatectomy. J Urol (2001) 1.14
The mitochondrial permeability transition. Biofactors (1998) 1.14
Study of regulation of mitochondrial respiration in vivo. An analysis of influence of ADP diffusion and possible role of cytoskeleton. Biochim Biophys Acta (1997) 1.12
Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells. J Biol Chem (2001) 1.12
Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein. Prostate (2000) 1.12
Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria. Int J Oncol (2006) 1.10
Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury. J Urol (1990) 1.09
Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium. Urol Oncol (2011) 1.09
Experience with retroperitoneal laparoscopic adrenalectomy for pheochromocytoma. J Urol (2001) 1.09
Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. Urology (1999) 1.08
Sensitivity of maximal aerobic power to training is genotype-dependent. Med Sci Sports Exerc (1984) 1.08
Pregnancy and vaginal delivery after augmentation cystoplasty. BJU Int (2003) 1.08
Determination of mitochondrial reactive oxygen species: methodological aspects. J Cell Mol Med (2002) 1.08
Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland. J Cell Biochem (2001) 1.05
Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology (1991) 1.03
Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy? J Urol (1999) 1.03
Characterisation of anaerobic curved rods (Mobiluncus spp.) isolated from the urogenital tract. J Med Microbiol (1987) 1.02
Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death. Prostate (1988) 1.01
Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors (1994) 1.01
Increased expression of class III beta-tubulin in castration-resistant human prostate cancer. Br J Cancer (2009) 1.00
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer (1999) 0.99
Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site. J Biol Chem (2000) 0.99
Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J Urol (1997) 0.98
Differences in steroid 5alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue. J Steroid Biochem Mol Biol (1999) 0.98
Spinal cord compression: an exceptional complication of spinal osteoporosis. Spine (Phila Pa 1976) (1988) 0.98
Genetic and cellular characteristics of bladder outlet obstruction. Urol Clin North Am (1995) 0.98
Posterior urethral valves: long-term renal function consequences after transplantation. J Urol (1997) 0.97
[Remote laparoscopic radical prostatectomy carried out with a robot. Report of a case]. Prog Urol (2000) 0.97
Gene expression during the early phases of regression of the androgen-dependent Shionogi mouse mammary carcinoma. Cancer Res (1988) 0.97
Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat. J Urol (2000) 0.96
Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach. Prostate Cancer Prostatic Dis (2002) 0.95
Early effects of castration on the vascular system of the rat ventral prostate gland. Endocrinology (1999) 0.95
Androgen suppressed apoptosis is modified in p53 deficient mice. Oncogene (1995) 0.95
Laparoscopic radical prostatectomy. The Créteil experience. Eur Urol (2001) 0.94
An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ (1999) 0.94
Protection of pancreatic INS-1 β-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin. Cell Death Dis (2011) 0.94
Factors governing expression of the herpes simplex virus gene for thymidine kinase in clonal derivatives of transformed mouse L cells. J Virol (1981) 0.94
Mitochondrial respiratory chain adjustment to cellular energy demand. J Biol Chem (2001) 0.93
Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. Am J Clin Pathol (2000) 0.93
Gene expression in response to acute unilateral ureteral obstruction. Kidney Int (1989) 0.92
Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate (1999) 0.91
Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor. Prostate (2000) 0.91
Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data: the role of secondary mutations. Antivir Ther (2001) 0.91
Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells. Prostate (2001) 0.91
Apoptosis: a general comment. FASEB J (1991) 0.91
Hormone-refractory prostate cancer: a multi-step and multi-event process. Prostate Cancer Prostatic Dis (2001) 0.91
Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping. Eur Urol (1999) 0.91
Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor. Antimicrob Agents Chemother (2001) 0.90
Prospective patient-reported continence after laparoscopic radical prostatectomy. Urology (2001) 0.90
Steroid receptor-nuclear matrix interactions. The role of DNA. J Biol Chem (1983) 0.90
On the regulation of cellular energetics in health and disease. Mol Cell Biochem (1997) 0.89
A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells. Int J Cancer (1999) 0.89
An early molecular response induced by acute overdistension of the rabbit urinary bladder. Mol Cell Biochem (1994) 0.89
[Round table: So-called idiopathic scolioses in the adult]. Rev Chir Orthop Reparatrice Appar Mot (1981) 0.88
Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide. J Cell Physiol (1995) 0.88
The microvascular architecture of the rat vagina revealed by image analysis of vascular corrosion casts. Int J Impot Res (1999) 0.88
Clusterin expression and apoptosis in tissue remodeling associated with renal regeneration. Kidney Int (1995) 0.88
Malignant pleural mesothelioma presenting with a spontaneous hydropneumothorax: a report of 2 cases. Rev Port Pneumol (2011) 0.88
Expression of human chorionic gonadotropin beta subunit genes in superficial and invasive bladder carcinomas. Cancer Res (1995) 0.88